Globus Medical Corp (GMED) - Market Value to Book Value Ratio

Globus Medical Corp - graphic logo of issuer GMED

The price action for Globus Medical, Inc. (GMED) is presented below for the specialized equipment manufacturer. Dan Scavilla's team is successfully finalizing the merger with a major asset, which is bolstering market confidence. Business efficiency relies on synergies with NuVasive and the development of ExcelsiusGPS robotics, with the indicator standing at 2.20. Growth is driven by the implementation of high-precision navigation systems that accelerate patient rehabilitation and expand the customer base.

NuVasive (GMED) Market Capitalization to Net Assets: for the period 07/04/2022 - 10/31/2026
Flagship merchandise of Globus Medical Inc

Post-merger integration challenges and regulatory barriers for Globus Medical, Inc. (GMED) surgical robots directly impact market confidence in the assets. By analyzing the company's market-to-book ratio, an investor can determine the degree to which prospects are discounted relative to equity, making it possible to identify asset overbought conditions and the risk of a correction should the valuation return to industry averages.

Competitor analysis

BSX: Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio EW|Market Value to Book Value Ratio ResMed|Insulet Corp (PODD) - Market Capitalization to Book Value|Market Value to Book Value Ratio Zimmer Biomet Holdings, Inc. (ZBH)|COO: Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio ALGN (Align Technology, Inc.)|TransMedics Organ Care System (TMDX) - Market-to-Book Ratio|Alphatec - Market Capitalization to Book Value Ratio|CryoLife (AORT) - Market Cap to Net Assets Ratio|ENOV: Market Capitalization to Book Value Ratio|IART - Market Capitalization to Book Value|ESTA (Establishment Labs) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio betabionics.com|Market Value to Book Value Ratio IRADIMED (IRMD)|Market Value to Book Value Ratio EMBC (Embecta Corp)|Market Capitalization to Book Value Ratio TNDM (Tandem Diabetes)|Market Capitalization to Book Value Axogen Surgical (AXGN)|SIBN: Market Cap to Net Assets Ratio|Market Capitalization to Net Assets OFIX|BVS: Market Capitalization to Book Value Ratio|Market-to-Book Ratio OrthoPediatrics (KIDS)|TMCI (Treace Medical) - Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio SRTA (Strata Medical)|Market Cap to Net Assets Ratio CARL (Carlsmed Inc)|RXST (rxsight.com) - Market Value to Book Value|Market Value to Book Value Ratio ClearPoint Neuro CLPT|STXS - Market Cap to Net Assets Ratio|NeuroStar - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Sight Sciences Inc|OBIO: Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio ANIK|NSPR (InspireMD) - Market Capitalization to Book Value Ratio|Jin Medical International Ltd (ZJYL) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio VANI|Market Cap to Net Assets Ratio xtantmedical.com XTNT|Market Capitalization to Book Value Ratio NMTC (NeuroOne Medical Technologies)|Market Capitalization to Book Value Ratio Modular Medical Inc MODD|MYO - Market Value to Book Value Ratio|COCH: Market Value to Book Value Ratio|VVOS (Vivos Therapeutics, Inc) - Market Cap to Net Assets Ratio|enVVeno Corp - Market Value to Book Value|SINT (Sintx Technologies Inc) - Market Capitalization to Book Value Ratio|Market-to-Book Ratio tenonmed.com TNON|Market Value to Book Value Ratio Lifeward (LFWD)|autonomix.com (AMIX) - Market Value to Equity Ratio|INVO Bioscience, Inc. - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio Bone Biologics Inc BBLG|Axonics, Inc. - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value biolase.com BIOL|dynatronics.com (DYNT) - Market Value to Book Value Ratio|Market Capitalization to Net Assets FNA (Paragon 28)|Market Value to Book Value Ratio INVO Bioscience Inc.